Global Geriatric Medicines Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 118 pages | ID: GE51AC09F13EN
GlobalInfoResearch

Abstracts

Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults.

Scope of the Report:

The global Geriatric Medicines market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Geriatric Medicines.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Geriatric Medicines market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Geriatric Medicines market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Eli Lilly and Company
• AstraZeneca
• Boehringer Ingelheim
• Abbott Laboratories
• Sanofi
• Bristol-Myers Squibb
• Merck
• Novartis
• Pfizer
• GSK

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Analgesics
• Antihypertensives
• Statins
• Antidiabetics
• Proton Pump Inhibitor
• Anticoagulant
• Antipsychotics
• Antidepressants

Market Segment by Applications, can be divided into

• Cardiovascular diseases
• Arthritis
• Neurological Disorders
• Cancer
• Osteoporosis
• Respiratory

Contents

1 GERIATRIC MEDICINES MARKET OVERVIEW

1.1 Product Overview and Scope of Geriatric Medicines
1.2 Classification of Geriatric Medicines by Types
  1.2.1 Global Geriatric Medicines Revenue Comparison by Types (2017-2023)
  1.2.2 Global Geriatric Medicines Revenue Market Share by Types in 2017
  1.2.3 Analgesics
  1.2.4 Antihypertensives
  1.2.5 Statins
  1.2.6 Antidiabetics
  1.2.7 Proton Pump Inhibitor
  1.2.8 Anticoagulant
  1.2.9 Antipsychotics
  1.2.10 Antidepressants
1.3 Global Geriatric Medicines Market by Application
  1.3.1 Global Geriatric Medicines Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Cardiovascular diseases
  1.3.3 Arthritis
  1.3.4 Neurological Disorders
  1.3.5 Cancer
  1.3.6 Osteoporosis
  1.3.7 Respiratory
1.4 Global Geriatric Medicines Market by Regions
  1.4.1 Global Geriatric Medicines Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Geriatric Medicines Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Geriatric Medicines Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Geriatric Medicines Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Geriatric Medicines Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Geriatric Medicines Status and Prospect (2013-2023)
1.5 Global Market Size of Geriatric Medicines (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Eli Lilly and Company
  2.1.1 Business Overview
  2.1.2 Geriatric Medicines Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Eli Lilly and Company Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca
  2.2.1 Business Overview
  2.2.2 Geriatric Medicines Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 AstraZeneca Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer Ingelheim
  2.3.1 Business Overview
  2.3.2 Geriatric Medicines Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Boehringer Ingelheim Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott Laboratories
  2.4.1 Business Overview
  2.4.2 Geriatric Medicines Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Abbott Laboratories Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi
  2.5.1 Business Overview
  2.5.2 Geriatric Medicines Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Sanofi Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb
  2.6.1 Business Overview
  2.6.2 Geriatric Medicines Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Bristol-Myers Squibb Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
  2.7.1 Business Overview
  2.7.2 Geriatric Medicines Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Merck Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
  2.8.1 Business Overview
  2.8.2 Geriatric Medicines Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Novartis Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
  2.9.1 Business Overview
  2.9.2 Geriatric Medicines Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Pfizer Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.10 GSK
  2.10.1 Business Overview
  2.10.2 Geriatric Medicines Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 GSK Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL GERIATRIC MEDICINES MARKET COMPETITION, BY PLAYERS

3.1 Global Geriatric Medicines Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Geriatric Medicines Players Market Share
  3.2.2 Top 10 Geriatric Medicines Players Market Share
3.3 Market Competition Trend

4 GLOBAL GERIATRIC MEDICINES MARKET SIZE BY REGIONS

4.1 Global Geriatric Medicines Revenue and Market Share by Regions
4.2 North America Geriatric Medicines Revenue and Growth Rate (2013-2018)
4.3 Europe Geriatric Medicines Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Geriatric Medicines Revenue and Growth Rate (2013-2018)
4.5 South America Geriatric Medicines Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Geriatric Medicines Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA GERIATRIC MEDICINES REVENUE BY COUNTRIES

5.1 North America Geriatric Medicines Revenue by Countries (2013-2018)
5.2 USA Geriatric Medicines Revenue and Growth Rate (2013-2018)
5.3 Canada Geriatric Medicines Revenue and Growth Rate (2013-2018)
5.4 Mexico Geriatric Medicines Revenue and Growth Rate (2013-2018)

6 EUROPE GERIATRIC MEDICINES REVENUE BY COUNTRIES

6.1 Europe Geriatric Medicines Revenue by Countries (2013-2018)
6.2 Germany Geriatric Medicines Revenue and Growth Rate (2013-2018)
6.3 UK Geriatric Medicines Revenue and Growth Rate (2013-2018)
6.4 France Geriatric Medicines Revenue and Growth Rate (2013-2018)
6.5 Russia Geriatric Medicines Revenue and Growth Rate (2013-2018)
6.6 Italy Geriatric Medicines Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC GERIATRIC MEDICINES REVENUE BY COUNTRIES

7.1 Asia-Pacific Geriatric Medicines Revenue by Countries (2013-2018)
7.2 China Geriatric Medicines Revenue and Growth Rate (2013-2018)
7.3 Japan Geriatric Medicines Revenue and Growth Rate (2013-2018)
7.4 Korea Geriatric Medicines Revenue and Growth Rate (2013-2018)
7.5 India Geriatric Medicines Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Geriatric Medicines Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA GERIATRIC MEDICINES REVENUE BY COUNTRIES

8.1 South America Geriatric Medicines Revenue by Countries (2013-2018)
8.2 Brazil Geriatric Medicines Revenue and Growth Rate (2013-2018)
8.3 Argentina Geriatric Medicines Revenue and Growth Rate (2013-2018)
8.4 Colombia Geriatric Medicines Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE GERIATRIC MEDICINES BY COUNTRIES

9.1 Middle East and Africa Geriatric Medicines Revenue by Countries (2013-2018)
9.2 Saudi Arabia Geriatric Medicines Revenue and Growth Rate (2013-2018)
9.3 UAE Geriatric Medicines Revenue and Growth Rate (2013-2018)
9.4 Egypt Geriatric Medicines Revenue and Growth Rate (2013-2018)
9.5 Nigeria Geriatric Medicines Revenue and Growth Rate (2013-2018)
9.6 South Africa Geriatric Medicines Revenue and Growth Rate (2013-2018)

10 GLOBAL GERIATRIC MEDICINES MARKET SEGMENT BY TYPE

10.1 Global Geriatric Medicines Revenue and Market Share by Type (2013-2018)
10.2 Global Geriatric Medicines Market Forecast by Type (2018-2023)
10.3 Analgesics Revenue Growth Rate (2013-2023)
10.4 Antihypertensives Revenue Growth Rate (2013-2023)
10.5 Statins Revenue Growth Rate (2013-2023)
10.6 Antidiabetics Revenue Growth Rate (2013-2023)
10.7 Proton Pump Inhibitor Revenue Growth Rate (2013-2023)
10.8 Anticoagulant Revenue Growth Rate (2013-2023)
10.9 Antipsychotics Revenue Growth Rate (2013-2023)
10.10 Antidepressants Revenue Growth Rate (2013-2023)

11 GLOBAL GERIATRIC MEDICINES MARKET SEGMENT BY APPLICATION

11.1 Global Geriatric Medicines Revenue Market Share by Application (2013-2018)
11.2 Geriatric Medicines Market Forecast by Application (2018-2023)
11.3 Cardiovascular diseases Revenue Growth (2013-2018)
11.4 Arthritis Revenue Growth (2013-2018)
11.5 Neurological Disorders Revenue Growth (2013-2018)
11.6 Cancer Revenue Growth (2013-2018)
11.7 Osteoporosis Revenue Growth (2013-2018)
11.8 Respiratory Revenue Growth (2013-2018)

12 GLOBAL GERIATRIC MEDICINES MARKET SIZE FORECAST (2018-2023)

12.1 Global Geriatric Medicines Market Size Forecast (2018-2023)
12.2 Global Geriatric Medicines Market Forecast by Regions (2018-2023)
12.3 North America Geriatric Medicines Revenue Market Forecast (2018-2023)
12.4 Europe Geriatric Medicines Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Geriatric Medicines Revenue Market Forecast (2018-2023)
12.6 South America Geriatric Medicines Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Geriatric Medicines Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Geriatric Medicines Picture
Table Product Specifications of Geriatric Medicines
Table Global Geriatric Medicines and Revenue (Million USD) Market Split by Product Type
Figure Global Geriatric Medicines Revenue Market Share by Types in 2017
Figure Analgesics Picture
Figure Antihypertensives Picture
Figure Statins Picture
Figure Antidiabetics Picture
Figure Proton Pump Inhibitor Picture
Figure Anticoagulant Picture
Figure Antipsychotics Picture
Figure Antidepressants Picture
Table Global Geriatric Medicines Revenue (Million USD) by Application (2013-2023)
Figure Geriatric Medicines Revenue Market Share by Applications in 2017
Figure Cardiovascular diseases Picture
Figure Arthritis Picture
Figure Neurological Disorders Picture
Figure Cancer Picture
Figure Osteoporosis Picture
Figure Respiratory Picture
Table Global Market Geriatric Medicines Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Geriatric Medicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Geriatric Medicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Geriatric Medicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Geriatric Medicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Geriatric Medicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Geriatric Medicines Revenue (Million USD) and Growth Rate (2013-2023)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Geriatric Medicines Type and Applications
Table Eli Lilly and Company Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Geriatric Medicines Type and Applications
Table AstraZeneca Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Geriatric Medicines Type and Applications
Table Boehringer Ingelheim Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Geriatric Medicines Type and Applications
Table Abbott Laboratories Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Geriatric Medicines Type and Applications
Table Sanofi Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Geriatric Medicines Type and Applications
Table Bristol-Myers Squibb Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Geriatric Medicines Type and Applications
Table Merck Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Geriatric Medicines Type and Applications
Table Novartis Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Geriatric Medicines Type and Applications
Table Pfizer Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Geriatric Medicines Type and Applications
Table GSK Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
Table Global Geriatric Medicines Revenue (Million USD) by Players (2013-2018)
Table Global Geriatric Medicines Revenue Share by Players (2013-2018)
Figure Global Geriatric Medicines Revenue Share by Players in 2016
Figure Global Geriatric Medicines Revenue Share by Players in 2017
Figure Global Top 5 Players Geriatric Medicines Revenue Market Share in 2017
Figure Global Top 10 Players Geriatric Medicines Revenue Market Share in 2017
Figure Global Geriatric Medicines Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Geriatric Medicines Revenue (Million USD) by Regions (2013-2018)
Table Global Geriatric Medicines Revenue Market Share by Regions (2013-2018)
Figure Global Geriatric Medicines Revenue Market Share by Regions (2013-2018)
Figure Global Geriatric Medicines Revenue Market Share by Regions in 2017
Figure North America Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Europe Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure South America Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Geriatric Medicines Revenue and Growth Rate (2013-2018)
Table North America Geriatric Medicines Revenue by Countries (2013-2018)
Table North America Geriatric Medicines Revenue Market Share by Countries (2013-2018)
Figure North America Geriatric Medicines Revenue Market Share by Countries (2013-2018)
Figure North America Geriatric Medicines Revenue Market Share by Countries in 2017
Figure USA Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Canada Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Mexico Geriatric Medicines Revenue and Growth Rate (2013-2018)
Table Europe Geriatric Medicines Revenue (Million USD) by Countries (2013-2018)
Figure Europe Geriatric Medicines Revenue Market Share by Countries (2013-2018)
Figure Europe Geriatric Medicines Revenue Market Share by Countries in 2017
Figure Germany Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure UK Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure France Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Russia Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Italy Geriatric Medicines Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Geriatric Medicines Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Geriatric Medicines Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Geriatric Medicines Revenue Market Share by Countries in 2017
Figure China Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Japan Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Korea Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure India Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Geriatric Medicines Revenue and Growth Rate (2013-2018)
Table South America Geriatric Medicines Revenue by Countries (2013-2018)
Table South America Geriatric Medicines Revenue Market Share by Countries (2013-2018)
Figure South America Geriatric Medicines Revenue Market Share by Countries (2013-2018)
Figure South America Geriatric Medicines Revenue Market Share by Countries in 2017
Figure Brazil Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Argentina Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Colombia Geriatric Medicines Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Geriatric Medicines Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Geriatric Medicines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Geriatric Medicines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Geriatric Medicines Revenue Market Share by Countries in 2017
Figure Saudi Arabia Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure UAE Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Egypt Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure Nigeria Geriatric Medicines Revenue and Growth Rate (2013-2018)
Figure South Africa Geriatric Medicines Revenue and Growth Rate (2013-2018)
Table Global Geriatric Medicines Revenue (Million USD) by Type (2013-2018)
Table Global Geriatric Medicines Revenue Share by Type (2013-2018)
Figure Global Geriatric Medicines Revenue Share by Type (2013-2018)
Figure Global Geriatric Medicines Revenue Share by Type in 2017
Table Global Geriatric Medicines Revenue Forecast by Type (2018-2023)
Figure Global Geriatric Medicines Market Share Forecast by Type (2018-2023)
Figure Global Analgesics Revenue Growth Rate (2013-2018)
Figure Global Antihypertensives Revenue Growth Rate (2013-2018)
Figure Global Statins Revenue Growth Rate (2013-2018)
Figure Global Antidiabetics Revenue Growth Rate (2013-2018)
Figure Global Proton Pump Inhibitor Revenue Growth Rate (2013-2018)
Figure Global Anticoagulant Revenue Growth Rate (2013-2018)
Figure Global Antipsychotics Revenue Growth Rate (2013-2018)
Figure Global Antidepressants Revenue Growth Rate (2013-2018)
Table Global Geriatric Medicines Revenue by Application (2013-2018)
Table Global Geriatric Medicines Revenue Share by Application (2013-2018)
Figure Global Geriatric Medicines Revenue Share by Application (2013-2018)
Figure Global Geriatric Medicines Revenue Share by Application in 2017
Table Global Geriatric Medicines Revenue Forecast by Application (2018-2023)
Figure Global Geriatric Medicines Market Share Forecast by Application (2018-2023)
Figure Global Cardiovascular diseases Revenue Growth Rate (2013-2018)
Figure Global Arthritis Revenue Growth Rate (2013-2018)
Figure Global Neurological Disorders Revenue Growth Rate (2013-2018)
Figure Global Cancer Revenue Growth Rate (2013-2018)
Figure Global Osteoporosis Revenue Growth Rate (2013-2018)
Figure Global Respiratory Revenue Growth Rate (2013-2018)
Figure Global Geriatric Medicines Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Geriatric Medicines Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Geriatric Medicines Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Geriatric Medicines Revenue Market Forecast (2018-2023)
Figure Europe Geriatric Medicines Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Geriatric Medicines Revenue Market Forecast (2018-2023)
Figure South America Geriatric Medicines Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Geriatric Medicines Revenue Market Forecast (2018-2023)